Clinical next-generation sequencing successfully applied to fine-needle aspirations of pulmonary and pancreatic neoplasms (Q34871953)

5 August 2017

title

Clinical next-generation sequencing successfully applied to fine-needle aspirations of pulmonary and pancreatic neoplasms (English)

1 reference

5 August 2017

Geneva Young

1

1 reference

5 August 2017

Kai Wang

2

1 reference

5 August 2017

Jie He

3

1 reference

5 August 2017

Geoff Otto

4

1 reference

5 August 2017

Matthew Hawryluk

5

1 reference

5 August 2017

Zac Zwirco

6

1 reference

5 August 2017

Tina Brennan

7

1 reference

5 August 2017

Michelle Nahas

8

1 reference

5 August 2017

Amy Donahue

9

1 reference

5 August 2017

Roman Yelensky

10

1 reference

5 August 2017

Doron Lipson

11

1 reference

5 August 2017

Christine E Sheehan

12

1 reference

5 August 2017

Ann B Boguniewicz

13

1 reference

5 August 2017

Philip J Stephens

14

1 reference

5 August 2017

Vincent A Miller

15

1 reference

5 August 2017

Jeffrey S Ross

16

1 reference

5 August 2017

publication date

24 July 2013

1 reference

5 August 2017

1 reference

5 August 2017

volume

121

1 reference

5 August 2017

issue

12

1 reference

5 August 2017

page(s)

688-694

1 reference

Fine needle aspiration cytology

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21338

Fine-needle aspiration biopsy versus core-needle biopsy in diagnosing lung cancer: a systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21338

Fine needle aspiration of non-small cell lung cancer: current state and future perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21338

Endoscopic ultrasound-guided fine-needle aspiration for non-small cell lung cancer staging: A systematic review and metaanalysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21338

Fine needle aspiration cytology of lung lesions: a clinicopathological and cytopathological review of 150 cases with emphasis on the relation between the number of passes and the incidence of pneumothorax

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21338

EUS-FNA and biomarkers for the staging of non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21338

Endoscopic ultrasound in the diagnosis of pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21338

EUS-guided FNA of solid pancreas tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21338

Interventional endoscopic ultrasonography for pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21338

Endoscopic ultrasound-guided fine needle aspiration of the pancreas: cytomorphological evaluation with emphasis on adequacy assessment, diagnostic criteria and contamination from the gastrointestinal tract

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21338

Role of endoscopic ultrasound in the diagnosis of patients with solid pancreatic masses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21338

Endoscopic ultrasound-guided fine-needle aspiration in 179 cases: the M. D. Anderson Cancer Center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21338

Epidermal growth factor receptor mutations, small-molecule kinase inhibitors, and non-small-cell lung cancer: current knowledge and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21338

Genotyping and genomic profiling of non-small-cell lung cancer: implications for current and future therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21338

Crizotinib for the treatment of ALK-rearranged non-small cell lung cancer: a success story to usher in the second decade of molecular targeted therapy in oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21338

International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21338

Biomarkers in pancreatic cancer: diagnostic, prognostic, and predictive.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21338

New biomarkers and targets in pancreatic cancer and their application to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21338

Diagnostic, prognostic, and predictive biomarkers in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21338

Targeted next-generation sequencing of advanced prostate cancer identifies potential therapeutic targets and disease heterogeneity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21338

Comparison of targeted next-generation sequencing (NGS) and real-time PCR in the detection of EGFR, KRAS, and BRAF mutations on formalin-fixed, paraffin-embedded tumor material of non-small cell lung carcinoma-superiority of NGS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21338

Clinical integration of next-generation sequencing technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21338

Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21338

Effectiveness of the cell block technique in diagnostic cytopathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21338

Functional analysis of receptor tyrosine kinase mutations in lung cancer identifies oncogenic extracellular domain mutations of ERBB2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21338

Targeting ROS1 with anaplastic lymphoma kinase inhibitors: a promising therapeutic strategy for a newly defined molecular subset of non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21338

Identifying and targeting ROS1 gene fusions in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21338

Chipping away at the lung cancer genome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21338

Monoclonal antibodies and other targeted therapies for pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21338

Emerging cell-cycle inhibitors for pancreatic cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21338

Pancreatic cancer: medical management (novel chemotherapeutics).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21338

Systemic treatment of advanced pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21338

Investigational therapies targeting the ErbB (EGFR, HER2, HER3, HER4) family in GI cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21338

EGFR and HER2 inhibition in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21338

Targeted therapy for lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21338

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CNCY.21338

1 reference

5 August 2017

1 reference